Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

Overview of attention for article published in JAMA Oncology, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 18 news outlets
blogs: 2 blogs
policy: 2 policy sources

twitter: 232 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 818 Dimensions

Readers on

mendeley: 451 Mendeley

Summary News Blogs Policy documents X Facebook Dimensions citations

So far, Dimensions has found 818 publications that cite this research output.

818

The most recent citing publications are shown below. View all 818 publications that cite this research output on Dimensions.

Early and repetitive novel-tracer PET-guided stereotactic body radiotherapy for nodal oligorecurrent prostate cancer after definitive first-line therapy

Article in Strahlentherapie und Onkologie (September 2024)

Stereotactic radiosurgery for patients with spinal metastases from prostate cancer

Article in Journal of Neuro-Oncology (September 2024)

STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC OVARIAN CANCER LYMPH NODE DISEASE: THE MITO-RT3/RAD PHASE II TRIAL stereotactic radiotherapy for ovarian cancer nodal metastases

Article in International Journal of Radiation Oncology • Biology • Physics (September 2024)